A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
Recruiting · NCT07219030 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants | Healthy Volunteer | Recruiting | Phase 1 | 2026-09-15 | NCT07219030 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Acpru /Id# 276996 | Grayslake | United States | 1 |
| Altasciences Clinical Los Angeles /ID# 276854 | Cypress | United States | 1 |
| Clinical Pharmacology Of Miami /ID# 276856 | Miami | United States | 1 |
| Hassman Research Institute Marlton Site /ID# 276876 | Marlton | United States | 1 |
| K2 Medical Research, LLC /ID# 276636 | Maitland | United States | 1 |